Status: current, Defined. Date: 31-Oct 2013. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3749581000168116 | Sevikar HCT 20/5/12.5 (amlodipine 5 mg + hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 30 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3750331000168117 | Sevikar HCT 20/5/12.5 tablet, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sevikar HCT 20/5/12.5 tablet, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Sevikar HCT 20/5/12.5 tablet, 30 | Is a | olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 | true | Inferred relationship | Some | ||
| Sevikar HCT 20/5/12.5 tablet, 30 | has TPUU | Sevikar HCT 20/5/12.5 tablet | true | Inferred relationship | Some | 1 | |
| Sevikar HCT 20/5/12.5 tablet, 30 | has TP | Sevikar HCT 20/5/12.5 | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sevikar HCT 20/5/12.5 tablet, 30, blister pack | Is a | True | Sevikar HCT 20/5/12.5 tablet, 30 | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
Trade product pack reference set
FHIR